Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

Clinical trial NCT06569472 · RECRUITING

Trial details

NCT number: NCT06569472
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Juvenile Dermatomyositis

Start date: 2024-07-02
Primary completion: 2027-07-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.